A recent study indicates that patients who come off popular weight-loss injections like Wegovy and Mounjaro tend to recover shed pounds at a significantly accelerated pace than those who halt traditional lifestyle regimens.
Findings released in a major health publication shows that while overweight individuals frequently drop about a fifth of their total mass while using the jabs, the mass returns at an average rate of nearly a kilo each month after stopping.
"People purchasing these medications should be cognizant of the risk of rapid weight regain when the treatment is stopped," stated expert Dr. Susan Jebb.
This pace of regain suggests a return to pre-treatment mass within about one and a half years.
Weighing Therapies
The analysis, which looked at dozens of trials involving over 9,000 of patients, contrasted the effects of these new drugs with older methods.
Scientists note that individuals who shed pounds through dieting usually experience a slower creep back—perhaps 0.1 kg a month—once they finish.
Understanding the Fast Regain
Doctors suggest the way of the drugs is key to understanding the heightened rebound.
The injections imitate a natural hormone called GLP-1, which helps regulate appetite.
"Artificially providing GLP-1 concentrations far above than the body's typical production could lead to the body to generate a reduced amount of its endogenous GLP-1, and could lessen responsiveness to its effects," noted Dr. Adam Collins, a dietetics expert.
"Withdrawal of this medication results in appetite is unsuppressed, making excessive eating a significant risk."
A Lifelong Disease?
Health authorities recommend the injections for people with weight-linked medical conditions, accompanied by prescribed lifestyle changes.
Professionals contend that, given the likelihood of relapse, the therapy might need to be long-term.
This view is reinforced by pharmaceutical companies, who note that the results "emphasize the long-term nature of obesity," comparing it to managing conditions like diabetes.
Patient Experiences
Users who have stopped the jabs report a powerful return of cravings.
"It was like a trigger that goes on and you become starving," described an individual.
This challenge is worsened if patients have not established lasting lifestyle or habit changes during therapy.
Significant Use
Figures show that millions of people in the UK have tried weight-loss jabs in the last 12 months, with interest remaining high.
- Adoption is more common among females than men.
- The 40s and 50s age group shows the greatest usage rates.
- A large proportion obtain the medications through private healthcare rather than the NHS.
In conclusion, experts emphasize that while GLP-1 drugs are potent tools for shedding pounds, they are not a magic solution and long-term success relies on combined behavioural support.
